What the Zepbound® documents cover
Brain fog is not a medical diagnosis, so it is unlikely to appear under that name in any label. The closer question is whether related terms such as confusion, memory impairment or disturbance in attention appear for Zepbound®. They do not: the US table built from SURMOUNT-1 and SURMOUNT-2 lists reactions in at least 2% of users and above placebo, the Canadian monograph goes down to 1%, and the EU information for tirzepatide (sold there as Mounjaro®) uses frequency bands; none includes a thinking or memory reaction. [1][3][4]
The documents do describe nearby problems, set out below.
| Finding | Zepbound® data | Source |
|---|---|---|
| Fatigue (asthenia, fatigue, lethargy, malaise) | 5 / 6 / 7% on 5 / 10 / 15 mg vs 3% placebo | US Table 1 [1] |
| Low blood sugar under 54 mg/dL | 4.2% vs 1.3% in SURMOUNT-2 (type 2 diabetes); 10.3% with a sulfonylurea; 0.3% vs 0% in SURMOUNT-1 | US §5.7, §6.1 [1] |
| Low blood pressure | 1.6% vs 0.1%, also seen with stomach side effects and dehydration | US §6.1 [1] |
| Malnutrition (weakness, feeling faint, fatigue, irritability, unable to pay attention) | Listed; frequency not known | Canadian patient information [3] |
| Severe low blood sugar (disorientation, loss of consciousness, seizure) | Listed as uncommon | Canadian patient information [3] |
Research on thinking and mood in SURMOUNT
The most Zepbound®-specific evidence comes from a 2026 post hoc analysis of SURMOUNT-1, -2 and -3, which included 4,056 adults with obesity and no known major psychiatric illness. Researchers collected nervous system and psychiatric adverse events throughout and found them generally similar with tirzepatide and placebo; depression questionnaire scores improved slightly more on tirzepatide. [5] The analysis was not designed to measure concentration or memory directly, so it cannot rule out subtle effects.
At the other extreme, a 2026 case report described a 50-year-old man with obesity and long-standing alcohol use disorder who developed Korsakoff syndrome, a serious memory disorder caused by thiamine (vitamin B1) deficiency, during rapid weight loss on tirzepatide. [6] It is a single case in a person with a major additional risk factor. The authors used it to argue for nutritional assessment when these treatments begin; it does not show that tirzepatide itself harms memory.
Five Zepbound®-linked reasons focus can slip
None of these is proven to cause brain fog on Zepbound®, but each is described in its documents or in public health sources.
- Tiredness. The fatigue row is one of the few non-digestive reactions in Table 1. [1] Cleveland Clinic lists fatigue and mental exhaustion among the ways brain fog feels. [9]
- Eating much less than before. Tirzepatide reduces calorie intake, probably through appetite. [1] Cleveland Clinic names poor nutrition among causes of brain fog, [9] and MedlinePlus lists deficiencies of thiamine, niacin and vitamin B12 among causes of confusion. [10]
- Low blood sugar. The risk rises with insulin or a sulfonylurea, [1] and confusion or drowsiness, blurred vision and slurred speech appear in the Medication Guide’s list of signs. [2]
- Dehydration or low blood pressure. Vomiting and diarrhea, most frequent during dose increases, can lead to fluid loss. [1] MedlinePlus lists irritability or confusion among signs of severe dehydration and fluid or electrolyte imbalance among causes of confusion. [10][11]
- Sleep apnea. The National Heart, Lung, and Blood Institute notes that daytime sleepiness from sleep apnea can cause problems with learning, focusing and reacting, [7] and MedlinePlus adds forgetfulness. [8] Zepbound® is approved to treat moderate to severe sleep apnea in adults with obesity, and it improved sleep-related impairment in its trials. [1]
Causes outside the medicine
Cleveland Clinic lists lack of sleep, stress, anxiety and depression, hormonal changes such as menopause, diabetes, autoimmune conditions, ADHD, long COVID and recent hospital stays among common causes of brain fog. [9] MedlinePlus adds alcohol, infections, fever, low oxygen levels, medicines and, in older people, early dementia as causes of confusion. [10]
Because many people start Zepbound® at a time of other changes, such as new medicines, a new exercise routine or menopause, it helps to note what else shifted in the same weeks.
What helps, according to general sources
The Zepbound® Medication Guide gives no brain-fog-specific advice, but its general points apply: drink fluids to lower the chance of dehydration, and talk with your prescriber about how to recognise and treat low blood sugar if you use insulin or a sulfonylurea. [2] Do not use Zepbound® alongside other tirzepatide or GLP-1 products. [2]
Cleveland Clinic suggests better sleep habits, nutritious meals, about 30 minutes of physical activity a day, writing important things down and taking short breaks during the day. [9] MedlinePlus advises that sudden confusion from low blood sugar, for example due to a diabetes medicine, be treated with a sweet drink or snack, and that the provider be contacted if it lasts longer than 10 minutes. [10] If your appetite is very low, ask your prescriber or a dietitian whether your eating pattern covers your needs; how that is assessed, and whether anything changes, is their decision.
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Confusion that comes on suddenly, or with fever, headache, fast pulse, cold or clammy skin, dizziness or fainting | Emergency services (911 or local number) | Emergency | MedlinePlus [10] |
| Sudden confusion in someone with diabetes, or loss of consciousness or a seizure | Emergency services | Emergency | MedlinePlus [10]; Canadian patient information [3] |
| Confusion from low blood sugar that lasts longer than 10 minutes after a sweet drink or snack | Contact the provider promptly | Today | MedlinePlus [10] |
| Weakness, feeling faint, irritability and trouble paying attention while eating very little | Talk to your prescriber (possible malnutrition) | Today | Canadian patient information [3] |
| Ongoing vomiting or diarrhea with thirst, dark urine or light-headedness | Your prescriber, the same day | Today | Medication Guide [2] |
| Brain fog that disrupts work or daily routines, or missed appointments | Raise it with your clinician | At your next appointment | Cleveland Clinic [9] |